CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To learn if cemiplimab can help to control dMMR colon cancer....
Phase 2
Gilbert, Arizona, United States and 4 other locations
with histologically or cytologically confirmed stage IV colorectal cancer coming form three different patient populations:* Cohort 1a: 6 pat...
Phase 1
Scottsdale, Arizona, United States and 11 other locations
and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...
Phase 2
Phoenix, Arizona, United States and 61 other locations
activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable (MSS)/Microsatellite Instability Low (MSI-L) Colorectal Cancer...
Phase 1
Phoenix, Arizona, United States and 9 other locations
This is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitr...
Phase 1
Phoenix, Arizona, United States and 32 other locations
to participants with advanced solid tumors, including rearranged during transfection (RET)-fusion-positive solid tumors, medullary thyroid cancer...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 85 other locations
The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with re...
Phase 1
Phoenix, Arizona, United States and 26 other locations
the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...
Phase 2, Phase 3
Phoenix, Arizona, United States and 1076 other locations
This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor...
Phase 1
Scottsdale, Arizona, United States and 3 other locations
This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced Cancer...
Phase 1, Phase 2
Phoenix, Arizona, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal